8-96835072-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016134.4(CPQ):c.533T>A(p.Ile178Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000548 in 1,461,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016134.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPQ | NM_016134.4 | c.533T>A | p.Ile178Asn | missense_variant | 3/8 | ENST00000220763.10 | NP_057218.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPQ | ENST00000220763.10 | c.533T>A | p.Ile178Asn | missense_variant | 3/8 | 1 | NM_016134.4 | ENSP00000220763 | P1 | |
CPQ | ENST00000517742.1 | c.533T>A | p.Ile178Asn | missense_variant | 4/4 | 5 | ENSP00000429146 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250426Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135362
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1461178Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726860
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.533T>A (p.I178N) alteration is located in exon 3 (coding exon 2) of the CPQ gene. This alteration results from a T to A substitution at nucleotide position 533, causing the isoleucine (I) at amino acid position 178 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at